218 related articles for article (PubMed ID: 33390901)
1. Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome.
Spendiff S; Howarth R; McMacken G; Davey T; Quinlan K; O'Connor E; Slater C; Hettwer S; Mäder A; Roos A; Horvath R; Lochmüller H
Front Mol Neurosci; 2020; 13():594220. PubMed ID: 33390901
[No Abstract] [Full Text] [Related]
2. Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia.
Webster RG; Vanhaesebrouck AE; Maxwell SE; Cossins JA; Liu W; Ueta R; Yamanashi Y; Beeson DMW
Hum Mol Genet; 2020 Aug; 29(14):2325-2336. PubMed ID: 32543656
[TBL] [Abstract][Full Text] [Related]
3. A valid mouse model of AGRIN-associated congenital myasthenic syndrome.
Bogdanik LP; Burgess RW
Hum Mol Genet; 2011 Dec; 20(23):4617-33. PubMed ID: 21890498
[TBL] [Abstract][Full Text] [Related]
4. Congenital myasthenic syndromes and the formation of the neuromuscular junction.
Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A
Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
[TBL] [Abstract][Full Text] [Related]
6. Dok-7/MuSK signaling and a congenital myasthenic syndrome.
Yamanashi Y; Higuch O; Beeson D
Acta Myol; 2008 Jul; 27(1):25-9. PubMed ID: 19108574
[TBL] [Abstract][Full Text] [Related]
7. Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions.
Nicole S; Azuma Y; Bauché S; Eymard B; Lochmüller H; Slater C
J Neuromuscul Dis; 2017; 4(4):269-284. PubMed ID: 29125502
[TBL] [Abstract][Full Text] [Related]
8. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Andreux F; Hantaï D; Eymard B
Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
[TBL] [Abstract][Full Text] [Related]
9. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
Rodríguez Cruz PM; Palace J; Beeson D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
[TBL] [Abstract][Full Text] [Related]
10. Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathway.
Beeson D; Cossins J; Rodriguez Cruz PM; Maxwell S; Liu WW; Palace J
Ann N Y Acad Sci; 2018 Feb; 1413(1):163-169. PubMed ID: 29363764
[TBL] [Abstract][Full Text] [Related]
11. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.
Clausen L; Cossins J; Beeson D
J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088
[TBL] [Abstract][Full Text] [Related]
12. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
[TBL] [Abstract][Full Text] [Related]
13. A Novel AGRN Mutation Leads to Congenital Myasthenic Syndrome Only Affecting Limb-girdle Muscle.
Zhang Y; Dai Y; Han JN; Chen ZH; Ling L; Pu CQ; Cui LY; Huang XS
Chin Med J (Engl); 2017 Oct; 130(19):2279-2282. PubMed ID: 28937031
[TBL] [Abstract][Full Text] [Related]
14. The Electrophysiology of Presynaptic Congenital Myasthenic Syndromes With and Without Facilitation: From Electrodiagnostic Findings to Molecular Mechanisms.
Nicolau S; Milone M
Front Neurol; 2019; 10():257. PubMed ID: 30941097
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Agrin and RhoA Pathways Ameliorates Movement Defects and Synapse Morphology in MYO9A-Depleted Zebrafish.
O'Connor E; Cairns G; Spendiff S; Burns D; Hettwer S; Mäder A; Müller J; Horvath R; Slater C; Roos A; Lochmüller H
Cells; 2019 Aug; 8(8):. PubMed ID: 31394789
[TBL] [Abstract][Full Text] [Related]
16. [Genetic defects and disorders at the neuromuscular junction].
Ohno K
Brain Nerve; 2011 Jul; 63(7):669-78. PubMed ID: 21747136
[TBL] [Abstract][Full Text] [Related]
17. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
[TBL] [Abstract][Full Text] [Related]
18. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
[TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndromes: recent advances.
Beeson D
Curr Opin Neurol; 2016 Oct; 29(5):565-71. PubMed ID: 27472506
[TBL] [Abstract][Full Text] [Related]
20. Novel NtA and LG1 Mutations in Agrin in a Single Patient Causes Congenital Myasthenic Syndrome.
Wang A; Xiao Y; Huang P; Liu L; Xiong J; Li J; Mao D; Liu L
Front Neurol; 2020; 11():239. PubMed ID: 32328026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
